-
The lancet oncology · Oct 2021
Comment LetterHER2-low-positive breast cancer from four neoadjuvant clinical trials - Authors' reply.
- Carsten Denkert, Valentina Nekljudova, and Sibylle Loibl.
- Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg (UK-GM), 35043 Marburg, Germany; GBG German Breast Group, Neu-Isenburg, Germany. Electronic address: carsten.denkert@uni-marburg.de.
- Lancet Oncol. 2021 Oct 1; 22 (10): e427.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:

- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.